DOV Pharmaceutical DOVP (news,
chart,
quote) - DOVP differential option implied volatility between April & May into event
DOVP is expected to release results for a phase 3 study of bicafadine in chronic lower back pain in the 2nd quarter. DOVP April option implied volatility is at 103, May is at 128. High May option implied volatility suggests larger price fluctuations after April expiration.
DISCLAIMER: RED Option, in an attempt to provide the best resources from some of the industry's most capable people, has introduced our Market Minute commentary. RED Option does not endorse this commentary or information as trade recommendations nor does it have any input whatsoever into the decision making. Any content for the Market Minute is the sole opinion of the author.
